These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18976251)

  • 21. Dental surgery with minimal factor support in the inherited bleeding disorder population at the Alfred Hospital.
    Hewson I; Makhmalbaf P; Street A; McCarthy P; Walsh M
    Haemophilia; 2011 Jan; 17(1):e185-8. PubMed ID: 20557354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction.
    Leissinger CA
    Am J Hematol; 2004 Oct; 77(2):187-93. PubMed ID: 15389908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care.
    Teitel JM; Carcao M; Lillicrap D; Mulder K; Rivard GE; St-Louis J; Smith F; Walker I; Zourikian N
    Haemophilia; 2009 Jan; 15(1):227-39. PubMed ID: 18752535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.
    Aleem A; Saidu A; Abdulkarim H; Al-Diab AR; Al-Sagheer A; Qayum A; Al-Momen AK
    Haemophilia; 2009 Jan; 15(1):210-6. PubMed ID: 19149851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of inhibitor development in haemophilia A patients treated with virus-inactivated plasma-derived clotting factor concentrates.
    Kreuz W; Escuriola-Ettingshausen C; Martinez-Saguer I; Kaiml M; Kornhuber B
    Vox Sang; 1999; 77 Suppl 1():3-8. PubMed ID: 10529676
    [No Abstract]   [Full Text] [Related]  

  • 26. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations.
    Jiménez-Yuste V; Alvarez MT; Martín-Salces M; Quintana M; Rodriguez-Merchan C; Lopez-Cabarcos C; Velasco F; Hernández-Navarro F
    Haemophilia; 2009 Jan; 15(1):203-9. PubMed ID: 19149850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors.
    Smith OP
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():22-5. PubMed ID: 12214142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.
    Keeling D; Tait C; Makris M
    Haemophilia; 2008 Jul; 14(4):671-84. PubMed ID: 18422612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of inhibitor against hemophilia and prevention and management strategies forpatients with hemophilia].
    Wu RH; Wei QQ
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):631-4. PubMed ID: 24225299
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach.
    Mannucci PM; Abshire T; Dimichele D; Santagostino E; Blanchette V
    Haemophilia; 2006 Jul; 12(4):429-34. PubMed ID: 16834746
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemophilia treatment. Side effects during immune tolerance induction.
    Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
    Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for the use of activated prothrombin complex concentrates (aPCCs) in the treatment of patients with haemophilia and inhibitors.
    Wilde JT
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():9-12. PubMed ID: 12214139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.
    van Helden PM; Kaijen PH; Mauser-Bunschoten EP; Fischer K; van den Berg HM; Voorberg J
    Haemophilia; 2010 Nov; 16(6):892-901. PubMed ID: 20491952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How I treat inhibitors in haemophilia.
    Makris M; Hay CR; Gringeri A; D'Oiron R
    Haemophilia; 2012 Jul; 18 Suppl 4():48-53. PubMed ID: 22726083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
    Astermark J; Rocino A; Von Depka M; Van Den Berg HM; Gringeri A; Mantovani LG; Morado M; Garrido RP; Schiavoni M; Villar A; Windyga J;
    Haemophilia; 2007 Jan; 13(1):38-45. PubMed ID: 17212723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of DDAVP in children with bleeding disorders.
    Ben-Ami T; Revel-Vilk S
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S41-3. PubMed ID: 23109357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision.
    Leblebisatan G; Sasmaz I; Antmen B; Kilinc Y; Sizmaz S; Yagmur M
    Haemophilia; 2006 Mar; 12(2):187-9. PubMed ID: 16476096
    [No Abstract]   [Full Text] [Related]  

  • 38. Suggestions for the management of factor VIII inhibitors.
    Rubinger M; Rivard GE; Teitel J; Walker H;
    Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
    [No Abstract]   [Full Text] [Related]  

  • 39. No increased bleeding risk for oral surgery in patients with severe congenital bleeding disorders due to intense perioperative management.
    Goldmann G; Berens C; Marquardt N; Reich R; Oldenburg J; Wenghoefer M
    Oral Maxillofac Surg; 2015 Jun; 19(2):195-200. PubMed ID: 25488716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor development in patients with hemophilia: an overview.
    Leissinger CA
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S1-2. PubMed ID: 16690370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.